Wendy V. Chavkin, MD, MPH, Physicians for Reproductive Health
Objectives: Since abortion laws were liberalized in Western Europe, conscientious objection (CO) to abortion has become increasingly contentious. The objectives of this study were to assess the efficacy and acceptability of national policies that attempt to enable both CO and access to legal abortion services. Do their regulations effectively permit CO while still ensuring that ...Read more >
Melody Hou, MD, MPH, University of California, Davis
Objectives: 1) to describe contraception counseling and bleeding complaints among women starting chemotherapy; 2) to estimate the satisfaction and bleeding patterns associated with a levonorgestrel containing intrauterine system (LNG-IUS) in women receiving chemotherapy. Methods: We performed a chart review of women 14-40 years old receiving chemotherapy from July 2008 to June 2013 at our institution. ...Read more >
Jessica Chavez, MA, New School for Social Research
Despite substantial evidence to the contrary, claims that abortion damages women’s mental health have been used to implement abortion regulations in the US. While studies demonstrating that abortion does not lead to negative mental health outcomes have important policy implications, they tend to control for the effects of income and exposure to violence, and in-depth ...Read more >
Kari Braaten, MD, MPH, Planned Parenthood League of Massachusetts
Objectives: To test an algorithm for determining IV sedation dosing that takes individual factors into account during first trimester surgical abortion. Methods: We conducted a randomized, single-blinded, controlled trial, comparing pain scores in patients undergoing first trimester surgical abortion, who receive IV sedation according to standard practice or an algorithm that determines dose based on ...Read more >
Alisa Goldberg, MD, MPH, Planned Parenthood League of Massachusetts
Objective: To evaluate adjunctive misoprostol or mifepristone versus overnight osmotic dilators alone for cervical preparation before dilation and evacuation at 16-23+6/7 weeks. Methods: This double-blind, three arm multicenter randomized trial compared osmotic dilators alone, dilators plus 400 mcg of buccal misoprostol 3 hours preoperatively and dilators plus 200 mg of oral mifepristone during dilator placement ...Read more >
Background: In both legally restricted and less restricted settings in Mexico, women purchase misoprostol in community pharmacies without a prescription and use it at home. Because these abortions occur outside the health-care system, little is known about how women learn about misoprostol, assess their eligibility, know appropriate dosing regimens, and recognize complications. Identifying and assessing ...Read more >
Deborah Bartz, MD, MPH, Brigham and Women's Hospital
Harvard Medical School is currently undergoing major curriculum reform, which provides a unique opportunity. Increased student exposure to abortion patients and science has the potential to improve understanding within the whole graduating medical school class, eventually increasing abortion sympathy of future physicians entering all medical specialties. This, in turn, may lead to expanded abortion provision ...Read more >
Priya Batra, MD, MS, University of California, Riverside
Though it is widely held that the restrictive policies regulating obtaining sterilization under Medicaid must be revised, no previous studies have proposed new process models. Our study addresses a critical gap in knowledge regarding Medicaid sterilization restrictions by developing a revised model of regulations grounded in the experiences of the very women impacted by current ...Read more >
Worldwide, concern about side effects and health risks is a key barrier to contraception use. Among women with an unmet contraceptive need in Latin America and the Caribbean, 35% reported contraception nonuse because of these concerns. These concerns often involve myths about contraception safety. Debunking these myths can be difficult as people have cognitive functions ...Read more >
As an Associate Professor in the Faculty of Health Sciences at the University of Ottawa, my research program is dedicated to conducting policy relevant and action- and intervention-oriented research on comprehensive reproductive health issues. My research includes multi-methods social science research and health policy analysis and I work at the local, provincial, national, and international ...Read more >
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy